APA (7th ed.) Citation

Averin, A., Law, A. W., Weycker, D., Atwood, M., Quinn, E., Atwell, J. E., . . . Shea, K. M. Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United States. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Averin, Ahuva, et al. Potential Public Health and Economic Impact of Maternal Vaccination with Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine for the Prevention of Acute Respiratory Infection Among Infants in the United States. Taylor & Francis Group.

MLA (9th ed.) Citation

Averin, Ahuva, et al. Potential Public Health and Economic Impact of Maternal Vaccination with Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine for the Prevention of Acute Respiratory Infection Among Infants in the United States. Taylor & Francis Group.